Second-line therapy with caspofungin for mucosal or invasive candidiasis: results from the caspofungin compassionate-use study. [electronic resource]
Producer: 20040713Description: 878-81 p. digitalISSN:- 0305-7453
- Adolescent
- Adult
- Aged
- Antifungal Agents -- adverse effects
- Candidiasis -- drug therapy
- Caspofungin
- Drug Resistance, Fungal
- Echinocandins
- Female
- HIV Infections -- complications
- Humans
- Lipopeptides
- Male
- Middle Aged
- Neutropenia -- complications
- Peptides -- adverse effects
- Peptides, Cyclic
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.